Chuan-Hsiung Chang

Title: The Innovative Contributions of Chuan-Hsiung Chang

Introduction: Chuan-Hsiung Chang is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cancer research through his innovative inventions. His work focuses on understanding the genetic factors associated with various cancers, particularly breast cancer.

Latest Patents: Chuan-Hsiung Chang holds a patent for an invention titled "ETS-related gene overexpressed in human breast and epithelial cancers." This invention provides a cDNA that represents a coding region of a previously unknown member of the ETS transcription regulator family. The gene, designated as ESX, is located at chromosome 1q32, a region amplified in 50% of early breast cancers. The ESX gene is associated with the etiology of various cancers, including breast cancers. Detection of the ESX gene or its product holds diagnostic and prognostic value.

Career Highlights: Chuan-Hsiung Chang is affiliated with the University of California, where he conducts his research. His work has garnered attention for its potential impact on cancer diagnostics and treatment. With a focus on genetic research, he continues to explore the complexities of cancer biology.

Collaborations: Some of his notable coworkers include Christopher C Benz and Gary K Scott. Their collaborative efforts contribute to advancing the understanding of cancer-related genetics.

Conclusion: Chuan-Hsiung Chang's innovative work in cancer research exemplifies the importance of genetic studies in understanding and diagnosing diseases. His contributions, particularly through his patent on the ESX gene, highlight the potential for advancements in cancer treatment and diagnostics.